Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Profit After Tax Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -12.28%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 21.98%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 22.89%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 20.02%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 49.66%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -7.65%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 29.05%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 15.46%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 -28.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.01%
Mar 31, 2026 70.58%
Dec 31, 2025 10.48%
Sep 30, 2025 21.05%
Jun 30, 2025 13.55%
Mar 31, 2025 9.71%
Dec 31, 2024 12.10%
Sep 30, 2024 17.65%
Jun 30, 2024 7.02%
Mar 31, 2024 28.23%
Dec 31, 2023 26.25%
Sep 30, 2023 37.20%
Jun 30, 2023 46.20%
Mar 31, 2023 -105.06%
Dec 31, 2022 5.74%
Sep 30, 2022 35.09%
Jun 30, 2022 17.64%
Mar 31, 2022 27.92%
Dec 31, 2021 17.83%
Sep 30, 2021 -15.35%